Screening compound: WODNANYVUDGUDH-UTRVAQADSA-N

Screening compound: WODNANYVUDGUDH-UTRVAQADSA-N
Screening compound: WODNANYVUDGUDH-UTRVAQADSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
WODNANYVUDGUDH-UTRVAQADSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C073-4468

Molecular Formula

C34H34N4O5 (C34 H34 N4 O5)

Compound Name

(1S,2R,5S,7R)-N~2~-cyclohexyl-4-oxo-N~6~-(4-phenoxyphenyl)-3-(3-pyridylmethyl)-10-oxa-3-azatricyclo[5.2.1.0~1,5~]dec-8-ene-2,6-dicarboxamide

IUPAC name

(5S7R)-N2-cyclohexyl-4-oxo-N6-(4-phenoxyphenyl)-3-[(pyridin-3-yl)methyl]-10-oxa-3-azatricyclo[5.2.1.0^{15}]dec-8-ene-26-dicarboxamide

SMILES

O=C(C([C@H]1C(N(Cc2cnccc2)C2C(NC3CCCCC3)=O)=O)[C@H]3O[C@@]12C=C3)Nc(cc1)ccc1Oc1ccccc1

InChI

InChI=1S/C34H34N4O5/c39-31(36-24-13-15-26(16-14-24)42-25-11-5-2-6-12-25)28-27-17-18-34(43-27)29(28)33(41)38(21-22-8-7-19-35-20-22)30(34)32(40)37-23-9-3-1-4-10-23/h2,5-8,11-20,23,27-30H,1,3-4,9-10,21H2,(H,36,39)(H,37,40)/t27-,28?,29-,30?,34-/m0/s1

InChI Key

WODNANYVUDGUDH-UTRVAQADSA-N

MDL Number (MFCD)

WODNANYVUDGUDH-UTRVAQADSA-N in Drug Discovery

Included in Screening Libraries

Cyclic Ugi PPI Library (9586 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with WODNANYVUDGUDH-UTRVAQADSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound WODNANYVUDGUDH-UTRVAQADSA-N?
Check Price and Availability of WODNANYVUDGUDH-UTRVAQADSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of WODNANYVUDGUDH-UTRVAQADSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for WODNANYVUDGUDH-UTRVAQADSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for WODNANYVUDGUDH-UTRVAQADSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of WODNANYVUDGUDH-UTRVAQADSA-N available by request